Niclosamide derivative enhances immune checkpoint blockade therapy for triple-negative breast cancer

Authors

• Zhipin Liang, LSU Health Sciences Center - New OrleansFollow
• Gabrielle R. Vontz, LSU Health Sciences Center - New OrleansFollow
• J. Li, University of Texas Medical Branch, Galveston, TX
• J. Zhou, University of Texas Medical Branch, Galveston, TX
• Qiang Shen, LSU Health Sciences Center - New OrleansFollow

Document Type

Conference Proceeding

Publication Date

9-1-2025

Publication Title

American Journal of the Medical Sciences

Abstract

2025 Southern Regional Meeting, February 13-15, 2025, New Orleans, LA

First Page

S201

Last Page

S202

Volume

369

Issue

Supplement 1

Comments

Abstract Number: 311

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.

Recommended Citation

Liang, Zhipin; Vontz, Gabrielle R.; Li, J.; Zhou, J.; and Shen, Qiang, "Niclosamide derivative enhances immune checkpoint blockade therapy for triple-negative breast cancer" (2025). School of Graduate Studies Faculty Publications. 573.
https://digitalscholar.lsuhsc.edu/sogs_facpubs/573
10.1016/S0002-9629(25)00318-0